T

Triumph Science&Technology Co Ltd
SSE:600552

Watchlist Manager
Triumph Science&Technology Co Ltd
SSE:600552
Watchlist
Price: 12.36 CNY -6.72% Market Closed
Market Cap: 11.7B CNY
Have any thoughts about
Triumph Science&Technology Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Triumph Science&Technology Co Ltd

Current Assets 5.3B
Cash & Short-Term Investments 753.6m
Receivables 2B
Other Current Assets 2.6B
Non-Current Assets 5.4B
PP&E 4.5B
Intangibles 823.5m
Other Non-Current Assets 48.2m
Current Liabilities 4.6B
Accounts Payable 675.3m
Accrued Liabilities 58.5m
Short-Term Debt 2.2B
Other Current Liabilities 1.6B
Non-Current Liabilities 2B
Long-Term Debt 1.4B
Other Non-Current Liabilities 568m

Balance Sheet
Triumph Science&Technology Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
398
801
188
317
218
241
544
678
661
302
Cash
0
0
0
0
0
0
0
179
661
302
Cash Equivalents
398
801
188
317
218
241
544
499
0
0
Short-Term Investments
0
15
0
3
45
89
0
0
737
71
Total Receivables
637
1 063
1 366
1 403
1 526
1 841
1 808
1 876
1 563
2 145
Accounts Receivables
392
773
1 011
1 019
1 060
1 394
1 317
1 181
934
1 293
Other Receivables
246
291
355
384
467
447
492
695
629
852
Inventory
200
742
952
1 157
1 566
1 688
1 740
1 849
1 919
2 039
Other Current Assets
99
232
422
340
457
543
549
242
434
863
Total Current Assets
1 334
2 853
2 928
3 220
3 812
4 403
4 642
4 645
5 313
5 419
PP&E Net
959
1 204
1 370
1 459
1 631
1 935
2 221
3 097
3 515
3 968
PP&E Gross
959
1 204
1 370
1 459
1 631
1 935
2 221
3 097
3 515
3 968
Accumulated Depreciation
257
360
393
490
558
587
652
1 235
1 487
1 548
Intangible Assets
133
264
351
326
343
340
433
512
549
607
Goodwill
0
254
254
232
196
196
196
196
196
192
Long-Term Investments
2
2
0
0
0
0
0
0
0
0
Other Long-Term Assets
4
25
28
30
38
42
41
57
54
47
Other Assets
0
254
254
232
196
196
196
196
196
192
Total Assets
2 432
N/A
4 601
+89%
4 931
+7%
5 266
+7%
6 021
+14%
6 916
+15%
7 533
+9%
8 509
+13%
9 626
+13%
10 233
+6%
Liabilities
Accounts Payable
94
370
570
424
612
793
803
975
648
800
Accrued Liabilities
21
35
39
35
38
62
73
112
102
86
Short-Term Debt
471
1 562
1 237
1 293
1 649
2 157
2 311
1 952
1 208
1 352
Current Portion of Long-Term Debt
0
40
6
36
705
134
857
366
827
1 169
Other Current Liabilities
17
137
159
142
92
58
110
538
1 163
1 194
Total Current Liabilities
603
2 144
2 011
1 928
3 096
3 203
4 153
3 942
3 948
4 600
Long-Term Debt
40
7
297
683
219
889
477
1 043
1 108
976
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
Minority Interest
17
104
132
159
186
229
277
293
385
422
Other Liabilities
62
84
133
126
117
104
92
99
103
158
Total Liabilities
722
N/A
2 339
+224%
2 573
+10%
2 896
+13%
3 618
+25%
4 426
+22%
4 999
+13%
5 376
+8%
5 544
+3%
6 157
+11%
Equity
Common Stock
359
384
384
767
764
764
764
764
945
945
Retained Earnings
410
521
597
636
679
767
811
485
549
623
Additional Paid In Capital
941
1 357
1 377
968
960
960
960
1 883
2 588
2 509
Total Equity
1 710
N/A
2 262
+32%
2 358
+4%
2 371
+1%
2 403
+1%
2 490
+4%
2 535
+2%
3 132
+24%
4 082
+30%
4 077
0%
Total Liabilities & Equity
2 432
N/A
4 601
+89%
4 931
+7%
5 266
+7%
6 021
+14%
6 916
+15%
7 533
+9%
8 509
+13%
9 626
+13%
10 233
+6%
Shares Outstanding
Common Shares Outstanding
718
767
767
767
764
764
764
764
945
945

See Also

Discover More